Oct 09, 2023

University Hospitals Sussex and Philips set to improve the diagnosis of heart disease with new Cardiac Catheter Laboratories this World Heart Day

Farnborough, United Kingdom – Royal Philips (NYSE: PHG, AEX: PHIA) – a global leader in health technology and University Hospitals Sussex NHS Foundation Trust, with a worldwide reputation for excellence in Cardiac care, celebrate the opening of new specialist Cardiac Catheter Lab, set to improve the diagnosis of heart disease for people in Sussex.

World Heart Day, celebrated globally today, is an annual event established by the World Heart Federation recognising the need to stop the world’s biggest killer: Cardiovascular Disease. In the UK, the NHS is focused on ensuring better care for this major health condition, with Heart Disease responsible for a quarter of all deaths with a fatality recorded every three minutes.

Over the two years, University Hospitals Sussex and Philips have joined forces to deliver a set of three Cardiac Catheter Labs within the hospitals’ Millenium Wing, providing new contemporary facilities to improve the diagnosis and treatment of patients with heart conditions across the region.

University Hospitals Sussex and Philips successfully completed the construction of the first Lab in 2021, with the second opening earlier this month. These transformational clinical spaces have been carefully designed to provide a calming and welcoming environment for patients, whilst equipping clinical teams to deliver more scans with greater diagnostic accuracy.

The Labs, fitted with innovative Philips Azurion imaging solutions mean patients are set to gain from more widely available and accurate diagnostic tests, pioneering techniques, and minimally invasive procedures in surgery, providing more treatment possibilities for patients with Cardiac conditions. The technology provided by Philips supports the health leader’s commitment to improve access to care for people with heart conditions around the world with Philips UK working with the NHS to advance cardiac services and support emergency cardiac arrest.

In extension to the partnership, University Hospitals Sussex will also be able to provide Cardiac Imaging for patients in the newly open Louisa Martindale building, fitted with three Philips Ingenia MRI systems. The announcement today therefore celebrates the expansion of the Trust’s cardiac services to cover all sites, with rehabilitation care also provided at St Richard’s Hospital, Worthing Hospital and Southlands hospitals.

This project was to future proof our cardiac cath labs for the next 10 years. We needed flexibility for different clinical procedures, the ability to modify in-room screen layouts and attach accessory imaging equipment to assist in decision-making during scanning and procedures. The image quality from the systems is fantastic and allows for easy diagnosis, positioning and reduction in screening and acquisition times. The effect this has had on dose is amazing, being able to use higher FPS while reducing doses substantially is a win for both clinicians and patients.

Michael Clarke

Superintendent at University Hospitals Sussex NHS Foundation Trust

Heart Disease is the single biggest opportunity for the NHS to save lives over the next 10 years and we must advance the quality and access to care for patients to help people live longer and healthier lives. We’re on a mission to support the transformation of the NHS despite pressures and by working together with the team at Sussex, we’ve been able to provide exceptional innovation to the frontline, that gives the opportunity for new levels of speed and productivity whilst enabling teams to deliver exceptional long-term care for their patients.

Mark Leftwich

Philips UK and Ireland Managing Director

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read more Click here to read less